Results 211 to 220 of about 133,418 (255)
Some of the next articles are maybe not open access.
Current Treatment Options in Gastroenterology, 1999
All infected patients with a peptic ulcer should be treated for H. pylori. The role of treating H. pylori in patients with undiagnosed dyspepsia or non-ulcer dyspepsia, those taking nonsteroidal anti-inflammatory medications, or with a family history of gastric cancer remains controversial.
openaire +2 more sources
All infected patients with a peptic ulcer should be treated for H. pylori. The role of treating H. pylori in patients with undiagnosed dyspepsia or non-ulcer dyspepsia, those taking nonsteroidal anti-inflammatory medications, or with a family history of gastric cancer remains controversial.
openaire +2 more sources
Lipid A in Helicobacter pylori
Infection and Immunity, 1992Free lipid A of Helicobacter pylori was characterized with regard to chemical composition, reactivity with anti-lipid A antibodies, and activity in a Limulus lysate assay. The predominant fatty acids of H. pylori lipid A were 3-OH-18:0, 18:0, 3-OH-16:0, 16:0, and 14:0.
I, Mattsby-Baltzer +4 more
openaire +2 more sources
Treatment of Helicobacter pylori
Best Practice & Research Clinical Gastroenterology, 2007Triple therapy, consisting of two antibiotics, clarithomycin and amoxicillin or metronidazole in combination with a proton pump inhibitor (PPI) has become the first-line option for infection with Helicobacter pylori and has been recommended at several consensus conferences.
K, Wolle, P, Malfertheiner
openaire +2 more sources
Heterogeneity of Helicobacter pylori
European Journal of Gastroenterology & Hepatology, 2012Although many physicians view Helicobacter pylori strains as a homogenous group of organisms, it has become increasingly clear that populations in humans are highly diverse. This heterogeneity can be analyzed at two different levels: genotypic variation among strains and variations in H. pylori populations within an individual host. Genotypic variation
openaire +3 more sources
Helicobacter pylori and endoscopy
Journal of Hospital Infection, 1999Helicobacter pylori is possibly the most common bacterial infection of humans and is now recognized as the most important acquired cause of peptic ulceration. Epidemiological evidence also recently implicated this bacterium in the pathogenesis of gastric cancer.
openaire +2 more sources
Helicobacter pylori and apoptosis
2002Publisher Summary Apoptosis associated with Helicobacter pylori (H. pylori) may be studied by one of the two approaches: either by staining human and animal gastric tissue sections, or by coculturing H. pylori with gastric cells in vitro. The advantage of a coculture system is that the target cell and bacterium may be readily manipulated, thus ...
Emilia Mia, Sordillo, Steven F, Moss
openaire +2 more sources
Immunoproteome of Helicobacter pylori
2002Publisher Summary This chapter describes how two-dimensional electrophoresis (2-DE) techniques can be combined with various immunoblotting procedures and how such data sets from infected patients can be evaluated in a semiquantitative manner as a basis for the development of sensitive and specific diagnostic tests.
Jungblut, Peter R., Bumann, Dirk
openaire +4 more sources
Treatment of Helicobacter pylori
Current Opinion in Gastroenterology, 2011The article will give an overview on reasons for treatment failure and tries to show new concepts for Helicobacter pylori treatment.Several new treatment options or modifications of already established regimens have been introduced to overcome treatment failure. Antibiotic resistance to H. pylori is the key factor for treatment failure.
Michael, Selgrad, Peter, Malfertheiner
openaire +2 more sources
Ugeskrift for laeger, 1992
Helicobacter pylori (HP) are Gram-negative spiral bacteria which occur in the human stomach. The bacteria were cultured in vitro for the first time in 1983. It is suspected that the bacteria may cause chronic gastritis of type B and may also be a contributory cause of chronic ulceration and cancer of the stomach.
openaire +2 more sources
Helicobacter pylori (HP) are Gram-negative spiral bacteria which occur in the human stomach. The bacteria were cultured in vitro for the first time in 1983. It is suspected that the bacteria may cause chronic gastritis of type B and may also be a contributory cause of chronic ulceration and cancer of the stomach.
openaire +2 more sources
Journal of Antimicrobial Chemotherapy, 1993
The discovery of Helicobacter pylori is arguably the most significant advance made in gastroduodenal pathology this century. It is the most important cause of chronic gastritis, and almost certainly the major aetiological factor responsible for duodenal ulcer and probably for gastric ulcer as well.
openaire +2 more sources
The discovery of Helicobacter pylori is arguably the most significant advance made in gastroduodenal pathology this century. It is the most important cause of chronic gastritis, and almost certainly the major aetiological factor responsible for duodenal ulcer and probably for gastric ulcer as well.
openaire +2 more sources